|
|
Volumn 39, Issue 9, 2001, Pages 65-68
|
|
▼Pioglitazone and ▼rosiglitazone for diabetes
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
GLUCOSE;
INSULIN;
METFORMIN;
PIOGLITAZONE;
ROSIGLITAZONE;
SULFONYLUREA;
TOLBUTAMIDE;
TROGLITAZONE;
2,4 THIAZOLIDINEDIONE DERIVATIVE;
THIAZOLE DERIVATIVE;
ALOPECIA;
ANEMIA;
ARTHRALGIA;
ARTICLE;
DIGESTIVE SYSTEM FUNCTION DISORDER;
DRUG APPROVAL;
DRUG CLASSIFICATION;
DRUG COST;
DYSPNEA;
FATIGUE;
FLATULENCE;
GLUCOSE BLOOD LEVEL;
HEADACHE;
HEMATURIA;
HUMAN;
HYPOGLYCEMIA;
IMPOTENCE;
INSULIN TREATMENT;
LEG EDEMA;
MAXIMUM TOLERATED DOSE;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PARESTHESIA;
PATIENT CARE;
PROTEINURIA;
RASH;
SIDE EFFECT;
SWEATING;
THROMBOCYTOPENIA;
UNITED KINGDOM;
VERTIGO;
VISUAL DISORDER;
WATER RETENTION;
WEIGHT GAIN;
DRUG COMBINATION;
REVIEW;
DIABETES MELLITUS, TYPE 2;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPOGLYCEMIC AGENTS;
THIAZOLES;
THIAZOLIDINEDIONES;
|
|
EID: 0034741183
PISSN: 00126543
EISSN: None
Source Type: Journal
DOI: 10.1136/dtb.2001.39965 Document Type: Article |
|
Times cited : (5)
|
|
References (14)
|
